Document Detail

Electrical and mechanical ventricular activation during left bundle branch block and resynchronization.
Jump to Full Text
MedLine Citation:
PMID:  22311563     Owner:  NLM     Status:  MEDLINE    
Cardiac resynchronization therapy (CRT) aims to treat selected heart failure patients suffering from conduction abnormalities with left bundle branch block (LBBB) as the culprit disease. LBBB remained largely underinvestigated until it became apparent that the amount of response to CRT was heterogeneous and that the therapy and underlying pathology were thus incompletely understood. In this review, current knowledge concerning activation in LBBB and during biventricular pacing will be explored and applied to current CRT practice, highlighting novel ways to better measure and treat the electrical substrate.
Marc Strik; François Regoli; Angelo Auricchio; Frits Prinzen
Related Documents :
9930513 - Facile left ventricular deairing by administration of cardioplegia into the left ventri...
20549343 - Left ventricular non-compaction and its cardiac and neurologic implications.
18180653 - Interventional treatments for stroke prevention in atrial fibrillation with emphasis up...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2012-02-07
Journal Detail:
Title:  Journal of cardiovascular translational research     Volume:  5     ISSN:  1937-5395     ISO Abbreviation:  J Cardiovasc Transl Res     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-03-06     Completed Date:  2012-10-09     Revised Date:  2013-06-26    
Medline Journal Info:
Nlm Unique ID:  101468585     Medline TA:  J Cardiovasc Transl Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  117-26     Citation Subset:  IM    
Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht 6200 MD, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bundle-Branch Block / physiopathology*,  therapy
Cardiac Resynchronization Therapy*
Treatment Outcome
Ventricular Function, Left / physiology*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): J Cardiovasc Transl Res
ISSN: 1937-5387
ISSN: 1937-5395
Publisher: Springer US, Boston
Article Information
Download PDF
© The Author(s) 2012
Received Day: 13 Month: 12 Year: 2011
Accepted Day: 21 Month: 1 Year: 2012
Electronic publication date: Day: 7 Month: 2 Year: 2012
pmc-release publication date: Day: 7 Month: 2 Year: 2012
Print publication date: Month: 4 Year: 2012
Volume: 5 Issue: 2
First Page: 117 Last Page: 126
ID: 3294208
PubMed Id: 22311563
Publisher Id: 9351
DOI: 10.1007/s12265-012-9351-1

Electrical and Mechanical Ventricular Activation During Left Bundle Branch Block and Resynchronization
Marc Strik13 Address: +31-43-3881200 +31-43-3884166
François Regoli2
Angelo Auricchio2
Frits Prinzen1
1Department of Physiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, 6200 MD the Netherlands
2Fondazione Cardiocentro Ticino, Lugano Ticino, Switzerland
3Department of Physiology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, the Netherlands


In the past decade, cardiac resynchronization therapy (CRT) has become an important treatment option for symptomatic heart failure patients with reduced left ventricular (LV) ejection fraction and abnormal QRS duration mostly in the form of left bundle branch block (LBBB). Until recently, little was known about the pathophysiology of the conduction disease and its adverse effects on ventricular contractility. Large clinical trials have shown that CRT benefits most patients but approximately one third of patients to not show clinical or echocardiographic response. Furthermore, further analysis of these studies show that the amount of responders was considerably higher in patients with LBBB as compared with patients without this conduction disease [1]. These aspects have revamped major interest in LBBB. This interest is further enforced by the difficulties of echocardiographic mechanical dyssynchrony measurements to adequately predict CRT response. Insight in electrical activation during LBBB and ventricular pacing during CRT has steadily increased over the last few years. LBBB appears to be the hallmark conduction disease that is treatable by CRT independently from etiology, as evidenced by efficacy of CRT in canine hearts with isolated LBBB and in CRT patients with LBBB compared to CRT patients with other conduction disorders [2, 3]. It is also becoming increasingly apparent that the site of LV stimulation, the electrical and mechanical activation patterns, and the presence of little or no scar are all critical for CRT success. In this paper, electrical and mechanical activation patterns during LBBB and CRT are discussed. Why these aspects are important for the delivery of a successful therapy is also shown.

Left Bundle Branch Block

One hundred years ago, Eppinger and Tothberger reported distinctive changes in QRS morphology after the destruction of only a small region in the interventricular septum in canine hearts [4]. Since the esophageal-to-rectal leads in the dogs were directly extrapolated to leads II and III in human patients, LBBB too was erroneously diagnosed as right bundle branch block (RBBB) and vice versa for 25 years. This misinterpretation illustrates the fact that the conduction disease was not considered important, and LBBB was solely considered a sign of poor prognosis. Only later it was discovered that most patients with LBBB who died shortly after diagnosis died of underlying heart disease and that the conduction disease on its own was not as dangerous as previously believed. It was not until 1972 that the anatomy of the left bundle branch (LBB) was described in more detail. A histopathological study in human patients without known cardiac disease, showed that the LBB is a continuation of the His bundle and initiates between the non-coronary and right-coronary aortic cusps. It runs as a 6 to 10-mm wide ribbon-like structure under the septal endocardium in inferior and anterior directions [5]. The fibers of the LBB fibers then separate to form fasciculi into anterior, posterior, and often septal radiations in heterogeneous patterns. Ultimately, the peripheral Purkinje fibers are coupled with individual (sub)endocardial myocardial cells which allows fast depolarization of the LV [6]. In isolated human hearts with an intact LBB, extensive electrical mapping showed up to three LV endocardial breakthrough sites which resulted in a rapid electrical activation of the LV [7].

Investigation of the electrical activation during LBBB can be performed in patients but is limited by the presence of comorbidities and the lack of knowledge concerning the duration and extent of the lesion (or lesions). Animal models can be used to specifically investigate the effects of isolated LBBB as discussed more extensively elsewhere in this edition [8]. Examples of three-dimensional activation time maps in a canine heart before and after induction of LBBB are shown in Fig. 1. In LBBB, onset of electrical activation occurs inside the right ventricle and the electrical wavefront then slowly propagates through the interventricular septum towards the lateral wall of the LV [9]. As is also shown in a schematic representation of transmural conduction during normal and LBBB conduction in humans (Fig. 2), LBBB reverses transseptal activation and causes large changes in QRS morphology and duration. Electrocardiographic imaging (ECGi, a novel technique that extracts estimated epicardial activation sequence from body surface maps) shows multiple epicardial conduction patterns in CRT candidates with LBBB of which an example is shown in Fig. 3 [10]. The LV endocardial activation sequence during LBBB has also proven to be heterogeneous in heart failure patients as shown by conventional point-by-point technique or three-dimensional electroanatomical reconstruction contact (Carto) and non-contact mapping (EnSite) technique. These studies have shown that in LBBB patients with heart failure, LV endocardial breakthrough is heterogenous and may occur at different septal regions [11, 12]. In some patients, breakthrough occurred in the mid-septal region, which could suggest activation by slow conduction through the LBB, in some others, via right-to-left transseptal activation as observed in dog models [11]. Narula reported in 1977 that by distal His-Bundle pacing in the right ventricle, he was able to abolish the electrocardiographic signs of LBBB in 25 patients, thereby “curing” the conduction disease. In these LBBB patients, the lesions were apparently located proximal in the rapid conduction system, just below the AV node [13].

The varying conduction patterns could thus be caused by one or more of the following aspects: (1) the varying structure of the LBB, (2) variability in the location of the LBB “block”, being either a proximal lesion or a more distal and diffuse disease, (3) LV hypertrophy and fibrosis as associated cellular uncoupling can result in increasing QRS duration and a LBBB-like QRS morphology [14]. The heterogeneous activation patterns seen in heart failure patients with LBBB might in part explain why CRT leads to varying amount of response. In addition, mentioned data accentuate the need for patient tailored therapy by carefully selecting the site of pacing and pacing settings.

Electrophysiological Evaluation of the CRT Candidate

The key clinical investigation to detect and evaluate the extent of ventricular conduction delay remains the surface electrocardiogram. To diagnose LBBB in patients, specific ECG criteria exist in addition to QRS width ≥120 ms such as a broad notched or slurred R wave in leads I, aVL, V5, and V6, an occasional RS pattern in V5 and V6 attributed to displaced transition of QRS complex, and absent q waves in leads I, V5, and V6 (in the absence of a large anterior-apical infarction) [15]. Note that although scar in the septum causes q waves in V1 to V3 when normal conduction is present, the same scar causes large R waves in V1 to V3 in the presence of LBBB because of unopposed electrical forces in the RV free wall [16]. When these criteria are not met, it is likely that patients have RBBB or slowed conduction by LV hypertrophy. Some heart failure patients with RBBB have been shown to have LV conduction delay similar to LBBB patients [17] but large trials have failed to show CRT response in these patients [1820]. Recently, it has been shown that patients with QRS duration >150 ms and LBBB morphology show the highest response rate in large multicenter trials [21, 22]. It should be mentioned however that in most CRT trials, patients were required to have QRS duration of at least 120 ms, and approximately one third of these patients did not have LBBB [3, 20]. On top of that, one third of patients diagnosed with LBBB by conventional electrocardiographic criteria may not have true complete LBBB but likely have a combination of left ventricular hypertrophy and left anterior fascicular block [9, 23]. A recent electrical mapping study showed that “true LBBB” was only seen in patients with a QRS duration exceeding 140 ms [24].

In the past decade, most efforts focused on finding dyssynchrony parameters to predict CRT response were based on echocardiography, which are discussed later in this review. Interestingly, recent studies have revamped the interest in using the surface ECG for exactly that purpose. An example is the PROSPECT trial where multiple echocardiography derived dyssynchrony parameters were investigated, followed by a sub-study where various ECG parameters were tested [22, 25]. In fact, LBBB morphology was the only parameter that was predictive for both volumetric and clinical response after 6 months (defined by LV end-systolic volume reduction of ≥15% and improvement in Clinical Composite Score, respectively). In addition, a broad QRS complex during single-site LV pacing was predictive of failure of volumetric response (OR = 0.86 per 10 ms increment). In non-ischemic patients, an LV paced QRS width of ≤200 ms was five times more likely to be associated with a positive response than having a LV paced QRS width greater than 200 ms, while no such difference was found in ischemic patients. The authors of this article postulate that LV paced QRS width may be an indirect method of identifying a region near scar or an area of poor conduction. Sweeney et al. [26] carefully inspected standard 12-lead electrocardiograms of 202 LBBB patients indicated for CRT. Based on the comparisons of baseline and post-implant electrocardiograms the authors introduced new measurements, which predicted CRT response (defined as at least 10% reduction in end-systolic volume as derived by echocardiography at 6 months). A notch, which occurred after 40 ms of QRS onset, was regarded as the transition from RV to LV depolarization and the time difference between this notch and the end of QRS was indicated as the LV activation time (LVATmax). QRS duration was weakly associated with reverse remodeling probability and this relationship was replaced by LVATmax in the multivariable model. A longer LVATmax at baseline was predictive of CRT response (OR 1.30 for each 10 ms increase up to 125, p = 0.001). The Selvester QRS score was used to quantify LV scar and a higher score was detrimental to volumetric response (OR 0.49 for each 1 point increase from 0 to 4, p = 0.002) [24]. The appearance of anterior forces in the precordial leads after implantation (change in R amplitude in V1 and V2 in expected direction) was also predictive of CRT response. An alternative method to estimate LV electrical asynchrony is by calculating the delay between QRS onset and LV lead depolarization. Varma found in heart failure patients that this delay exceeded 100 ms in 87% of LBBB patients as compared to 45% of RBBB patients, even though there was no difference in QRS duration [27]. Singh et al. [28] showed that CRT patients with a reduced LV lead electrical delay (<50% of the QRS duration) before biventricular pacing was associated with worse clinical outcome at 12 months.

Studies investigating electrocardiography beyond surface ECG or pacemaker lead electrograms are even scarcer because evaluation of cardiac electrical activation sequence by catheter mapping in CRT candidates is time-consuming, cumbersome, and not without risk. Lines of conduction block are seen in most LBBB patients as shown by endocardial (EnSite) and epicardial (ECGi) non-contact mapping studies [10, 12]. The implications of these lines of block have been investigated in a small observational study where non-contact mapping was performed in 23 CRT candidates [29]. Twelve of the 18 patients who had lines of conduction block before implantation were volumetric CRT responders at 3 months as opposed to one of the eight patients who had homogeneous endocardial conduction (p = 0.01). This study confirmed that the benefit of CRT is more dependent on specific LV activation patterns rather than on total LV activation time, which could explain why LVATmax beyond 125 ms, and in some studies QRS duration, are poor individual predictors of response [26, 30].

Mechanical Evaluation of the CRT Candidate

Although the underlying pathophysiological mechanisms of how LBBB induces left ventricular dysfunction remain to be clarified, LBBB yields a disturbance of mechanical coordination between the different regions of the left ventricular walls, especially between septum and lateral wall. Moreover, the extremely variable and relatively unpredictable nature of response to CRT remains puzzling. Transthoracic echocardiography represents a non-invasive method that has been used to address some of these issues. The first measurements such as interventricular mechanical delay, septal posterior wall motion delay and pulsed-wave, color-coded tissue Doppler imaging were all measures of myocardial regional mechanical delay in patients with heart failure and ventricular conduction delays (mostly LBBB, Table 1) [25, 31, 32]. The very promising initial findings derived mainly from single center studies, showing excellent predictive value of these parameters were offset by the more recent results of the PROSPECT and J-CRT trials [25, 33]. In these trials, area under receiver-operating characteristics curve (ROC) for positive clinical or volume response after CRT was ≤0.62. Possible reasons accounting for the shortcomings of these measures include inability to discern passive from active wall movements, limited 2-D plane and operator dependency. However, some studies showed that timing parameters as determined by the gold-standard deformation technique of MRI tagging were also not able to predict CRT response, indicating that timing parameters may have intrinsic limitations [34].

Further development of echocardiographic methodologies coupled with the advances in the field of cardiac magnetic resonance have provided greater depth of understanding in the complex mechanical myocardial wall behavior during LBBB. Some additional aspects of the physiology of myocardium wall motion during LBBB should be taken into account. Myocardial fiber spatial disposition in three different layers cause the mechanical contractile movement to be nonsymmetrical and in different directions. Myocardial contractile thickening has been observed to be longitudinal, circumferential, and radial, thus conferring a movement of torsion during systole [35]. In the context of important ventricular conduction delay such as LBBB, myocardial regional motion is characterized by complex and multiphasic mechanical behavior [36]. It follows therefore that measures evaluating global wall motion or myocardial efficiency in all three different perspectives, rather than regional two-dimensional measures, may be more suitable to characterize contractile mechanics during LBBB. With these notions, echocardiography has manifested a new drive in the last few years with the emergence of new dyssynchrony measures. The most widely used technique for the detection of myocardial deformation by discriminating active from passive wall motion is speckle tracking imaging (STI) strain. By considering the sum of the difference between peak and end-systolic strain across 16 segments (strain delay index), Lim et al. [37] found that longitudinal strain by STI in HF patients with ventricular conduction delay was predictive of CRT response. Another study by Klimusina et al. [38] utilized segmental peak myocardial strain in heart failure patients derived from speckle tracking and showed that heart failure patients with intraventricular conduction delay presented heterogeneity in longitudinal and radial strain distributions, with amplitudes being particularly low in the septum and higher in the lateral and posterior walls. Based on the Speckle Tracking and Resynchronization Study (STAR) for prediction of volume response after CRT, ROC for circumferential and longitudinal speckle-tracking was 0.59 and 0.57, respectively, whereas that of radial and transverse strain was superior (0.79 and 0.75, respectively). It should be mentioned however that a proportion of patients without detected dyssynchrony nevertheless showed reverse remodeling after CRT; these patients were most likely to present a wide QRS and non-ischemic heart failure etiology [39]. One of the most promising echocardiographic indices is Septal Rebound Stretch (SRSsept). SRSsept is defined as systolic stretch occurring after initial shortening in the early activated septum. De Boeck et al. [40] showed that SRSsept strongly correlated with an increase in LV ejection fraction after CRT as well as a reduction in LVESV and brain natriuretic peptide. SRSsept predicted a 15% reduction in LVESV with an AUC of 0.81.

Cardiac magnetic resonance is a high resolution image modality which allows complex and global assessment not only of cardiac morphology, but also function. Indeed, this imaging modality has emerged to become the “gold-standard” for the characterization of myocardial contractile behavior. By using MRI tagging, time plots of strain are generated for each segment in each short-axis slice, and the circumferential uniformity ratio estimate (CURE) is calculated [41]. This ratio considers “0” most dyssynchronous and “1” absence of dyssynchrony. A CURE cut-off of <0.75 accurately predicts symptomatic response after CRT [42]. An important additional aspect is that CURE uses information from the full cardiac cycle and not only time-to-peak. The paucity of consistent prospective, multicenter data on echocardiographic and CMR parameters estimating LV dyssynchrony during LBBB, along with the expensive, time-consuming, and knowledge-intensive nature of these investigations, have limited the diffusion of such technologies to select the adequate CRT candidate.

CRT in the Ischemic Dyssynchronous Heart

Most studies show that CRT response is higher in non-ischemic patients [43, 44]. A possible mechanism lies in modification of the electrical substrate. According to this idea, the extent of resynchronization would be limited as a result of slow-conducting or non-conducting regions. This would mean that a good response to CRT not only requires clear conduction disease, but also the capability to properly resynchronize the heart. Figure 4 shows examples of how an LAD or LCX infarction can influence electrical resynchronization in dogs with LBBB. An important feature in this regard is the site of pacing as pacing in the vicinity of scar tissue can compromise conduction. In canine hearts with LBBB and transmural infarction, pacing away from the infarcted regions resulted in a similar CRT response as in non-infarcted canine LBBB hearts [45].

In line with the pre-clinical data, clinical response after CRT is assumed to involve three key factors: lead position (in relation to area of greatest delay or vicinity to scar tissue), the presence of discoordinate and inefficient area of myocardial contractility, and quantity/degree of scarred tissue. However, rapid, effective, and integrated assessment of these features in the diagnostic build-up of patients considered for CRT, remains an unresolved challenge. Furthermore, the present literature offering aid remains scanty. Some important single center studies have shown how measures derived from CMR may be of great use. The relation between scar and left ventricular lead deployment has been unveiled using CMR late gadolinium enhancement [46, 47]. This method, besides emphasizing how scar size and transmurality were associated to a dismal prognosis after CRT, also showed how pacing scar localized in a postero-lateral area reduces CRT response rate. Another CMR study, which examined the relationship between left ventricular myocardial dyssynchrony (circumferential uniformity ratio estimate derived from myocardial tagging—MT) and scar location (delayed enhancement—DE), found that functional class improvement after CRT was predicted by MT and that DE offered further predictive value [42]. Though the data are limited, there is no doubt that the development of integrated measures derived from CMR may be of great use to improve selection eligible for CRT (see Table 1).

Worthy to mention is the study by Delgado et al. [48] who have addressed the relative influence of ventricular dyssynchrony, left ventricular lead position, and myocardial scar on the long-term prognosis of patients treated with CRT. Through the use of two-dimensional speckle tracking radial strain imaging LV dyssynchrony (difference between the earliest and latest of six segments) was measured and the regions of scar were identified (considered segments with peak radial strain value <16.5%). After CRT, the influence of LV lead position was assessed retrospectively radiographically and placed in relation to the segment of greatest delay or the area of scar. The investigators found that the independent predictors of unfavorable prognosis after CRT were discordant LV lead position with respect to the radial segment of greatest delay and the presence of myocardial scar at the level of the pacing lead. A significantly better prognosis was found in patients with a substantial time delay between the antero-septal and posterior segments (≥130 ms). In spite of the methodological limits of the study, i.e., only radial strain to assess left ventricular dyssynchrony [49] and simple retrospective radiographical assessment of lead position, this study is the first which demonstrates how lead position, electro-mechanical delay, and presence of scar are inextricably linked and impact on the prognosis of CRT patients. Leyva et al. [47] also showed that LV lead position inside the scar region results in a fivefold risk of pump failure and sudden cardiac death as compared to patients with no scar and patients with scar, but LV lead positioned elsewhere combined. Besides avoiding scar tissue, the position of the LV could also be improved by moving from the epicardium (epicardial implant or coronary sinus) to the endocardium. Under physiological conditions, excitation of the LV initiates at the endocardium [7] while in CRT, the LV is most often paced at the epicardial surface. As discussed, conventional CRT can resynchronize the heart but not to (near) normal conditions. In canine LBBB hearts with myocardial infarction, endocardial LV pacing during CRT consistently improved systolic LV pump function, reduced electrical dyssynchrony and decreased dispersion of repolarization, as compared to epicardial LV pacing at the same site (Fig. 5) [50]. Additionally, the hemodynamic effects for endocardial sites were less dependent on location and AV-delay than epicardial sites. The added benefit of endocardial CRT was also seen in dogs with heart failure (induced by tachypacing) [50] and in dogs with isolated LBBB [51]. Support for these experimental findings come from studies by Spragg et al. [52] in seven ICM patients where LV endocardial and epicardial pacing at immediately transmural sites gave equivalent LV dP/dtmax values. However, LV dP/dtmax at best LV endocardial sites was greater than conventional CRT. Given individual variations in etiology, severity, patterns of delayed ventricular activation, location of regions of scar, and extent of mitral regurgitation in heart failure, it seems indeed unlikely that one pacing site will “fit all”. Individual tailoring of endocardial CRT by searching the optimal pacing site within the endocardium is warranted. LV endocardial pacing in humans can be established through an atrial transseptal approach [53, 54] or a left transapical approach can be used [55]. In the future, wireless endocardial LV stimulation [56] might become the most feasible approach.


Left bundle branch block results in asynchronous electrical activation, which can be largely reversed by CRT, thus conferring favorable clinical effects. It is imperative that correct electrical substrate, preferably in the form of true left bundle branch block, coexists with adequate morphological and anatomical conditions to allow adequate CRT delivery. In the future, integrated multi-modality imaging presents the central and challenging task to transfer pre-clinical knowledge into clinical practice, hence further defining the complex mechanical and functional effects of LBBB. On the other hand, with the aid of endocardial LV pacing, with- or without RV pacing, patient-specific tailoring of CRT will likely increase therapy success.


This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (, project COHFAR (grant 01C-203), and supported by the Dutch Heart Foundation.

Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

1.. Strik M,Ploux S,Vernooy K,Prinzen FW. Cardiac resynchronization therapy: refocus on the electrical substrateCirculation JournalYear: 2011751297130410.1253/circj.CJ-11-035621532178
2.. Vernooy K,Cornelussen RN,Verbeek XA,Vanagt WY,Hunnik A,Kuiper M,et al. Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block heartsEuropean Heart JournalYear: 2007282148215510.1093/eurheartj/ehm20717611254
3.. Bilchick KC,Kamath S,DiMarco JP,Stukenborg GJ. Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in medicare patientsCirculationYear: 20101222022203010.1161/CIRCULATIONAHA.110.95601121041691
4.. Eppinger H,Rothberger J. Ueber die folgen der durchschneidung der tawaraschen schenkel des reizleitungssystemsZeitschrift für Klinische MedizinYear: 191070120
5.. Demoulin JC,Kulbertus HE. Histopathological examination of concept of left hemiblockBritish Heart JournalYear: 19723480781410.1136/hrt.34.8.8075070112
6.. Massing GK,James TN. Anatomical configuration of the his bundle and bundle branches in the human heartCirculationYear: 1976536096211253382
7.. Durrer D,Dam RT,Freud GE,Janse MJ,Meijler FL,Arzbaecher RC. Total excitation of the isolated human heartCirculationYear: 1970418999125482907
8.. Strik, M., van Middendorp, L. B., & Vernooy, K. (2011). Animal models of dyssynchrony. Journal of Cardiovascular Translational Research. doi:10.1007/s12265-011-9336-5.
9.. Vassallo JA,Cassidy DM,Marchlinski FE,Buxton AE,Waxman HL,Doherty JU,et al. Endocardial activation of left bundle branch blockCirculationYear: 19846991492310.1161/01.CIR.69.5.9146705167
10.. Jia P,Ramanathan C,Ghanem RN,Ryu K,Varma N,Rudy Y. Electrocardiographic imaging of cardiac resynchronization therapy in heart failure: observation of variable electrophysiologic responsesHeart RhythmYear: 20063Jia P, Ramanathan C, Ghanem RN, Ryu K, Varma N, Rudy Y29631010.1016/j.hrthm.2005.11.02516500302
11.. Rodriguez LM,Timmermans C,Nabar A,Beatty G,Wellens HJ. Variable patterns of septal activation in patients with left bundle branch block and heart failureJournal of Cardiovascular ElectrophysiologyYear: 20031413514110.1046/j.1540-8167.2003.02421.x12693492
12.. Auricchio A,Fantoni C,Regoli F,Carbucicchio C,Goette A,Geller C,et al. Characterization of left ventricular activation in patients with heart failure and left bundle-branch blockCirculationYear: 20041091133113910.1161/01.CIR.0000118502.91105.F614993135
13.. Narula OS. Longitudinal dissociation in the his bundle. Bundle branch block due to asynchronous conduction within the His bundle in manCirculationYear: 1977569961006923070
14.. Bacharova L,Mateasik A,Krause R,Prinzen FW,Auricchio A,Potse M. The effect of reduced intercellular coupling on electrocardiographic signs of left ventricular hypertrophyJournal of ElectrocardiologyYear: 20114457157610.1016/j.jelectrocard.2011.06.00421757205
15.. Surawicz B,Childers R,Deal BJ,Gettes LS,Bailey JJ,Gorgels A,et al. Aha/accf/hrs recommendations for the standardization and interpretation of the electrocardiogram: Part III: intraventricular conduction disturbancesJournal of the American College of CardiologyYear: 20095397698110.1016/j.jacc.2008.12.01319281930
16.. Strauss DG,Selvester RH,Lima JA,Arheden H,Miller JM,Gerstenblith G,et al. Ecg quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesisCirculation. Arrhythmia and ElectrophysiologyYear: 2008132733610.1161/CIRCEP.108.79866019808427
17.. Fantoni C,Kawabata M,Massaro R,Regoli F,Raffa S,Arora V,et al. Right and left ventricular activation sequence in patients with heart failure and right bundle branch block: a detailed analysis using three-dimensional non-fluoroscopic electroanatomic mapping systemJournal of Cardiovascular ElectrophysiologyYear: 20051611211910.1046/j.1540-8167.2005.40777.x15720446
18.. Tang, A. S., Wells, G. A., Talajic, M., Arnold, M. O., Sheldon, R., Connolly, S., et al. (2010). Cardiac-resynchronization therapy for mild-to-moderate heart failure. The New England Journal of Medicine. doi:10.1056/NEJMoa1009540.
19.. Gervais R,Leclercq C,Shankar A,Jacobs S,Eiskjaer H,Johannessen A,et al. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the care-hf trialEuropean Journal of Heart FailureYear: 20091169970510.1093/eurjhf/hfp07419505883
20.. Zareba W,Klein H,Cygankiewicz I,Hall WJ,McNitt S,Brown M,et al. Effectiveness of cardiac resynchronization therapy by qrs morphology in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (madit-crt)CirculationYear: 20111231061107210.1161/CIRCULATIONAHA.110.96089821357819
21.. Sipahi, I., Carrigan, T. P., Rowland, D. Y., Stambler, B. S., & Fang, J. C. (2011). Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Archives of Internal Medicine. doi:10.1001/archinternmed.2011.247.
22.. Hsing, J. M., Selzman, K. A., Leclercq, C., Pires, L. A., McLaughlin, M. G., McRae, S. E., et al. (2011). Paced left ventricular qrs width and ecg parameters predict outcomes after cardiac resynchronization therapy: prospect-ECG sub-study. Circulation. Arrhythmia and Electrophysiology. doi:10.1161/CIRCEP.111.962605.
23.. Grant RP,Dodge HT. Mechanisms of QRS complex prolongation in man; left ventricular conduction disturbancesAmerican Journal of MedicineYear: 19562083485210.1016/0002-9343(56)90204-213326898
24.. Strauss DG,Selvester RH. The QRS complex—a biomarker that “images” the heart: QRS scores to quantify myocardial scar in the presence of normal and abnormal ventricular conductionJournal of ElectrocardiologyYear: 200942859610.1016/j.jelectrocard.2008.07.01118790501
25.. Chung ES,Leon AR,Tavazzi L,Sun JP,Nihoyannopoulos P,Merlino J,et al. Results of the predictors of response to CRT (prospect) trialCirculationYear: 20081172608261610.1161/CIRCULATIONAHA.107.74312018458170
26.. Sweeney MO,Bommel RJ,Schalij MJ,Borleffs CJ,Hellkamp AS,Bax JJ. Analysis of ventricular activation using surface electrocardiography to predict left ventricular reverse volumetric remodeling during cardiac resynchronization therapyCirculationYear: 201012162663410.1161/CIRCULATIONAHA.109.89477420100970
27.. Varma N. Left ventricular conduction delays and relation to qrs configuration in patients with left ventricular dysfunctionThe American Journal of CardiologyYear: 20091031578158510.1016/j.amjcard.2009.01.37919463519
28.. Singh JP,Fan D,Heist EK,Alabiad CR,Taub C,Reddy V,et al. Left ventricular lead electrical delay predicts response to cardiac resynchronization therapyHeart RhythmYear: 200631285129210.1016/j.hrthm.2006.07.03417074633
29.. Fung JW,Chan JY,Yip GW,Chan HC,Chan WW,Zhang Q,et al. Effect of left ventricular endocardial activation pattern on echocardiographic and clinical response to cardiac resynchronization therapyHeartYear: 20079343243710.1136/hrt.2007.11529517237127
30.. Mollema SA,Bleeker GB,Wall EE,Schalij MJ,Bax JJ. Usefulness of qrs duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failureThe American Journal of CardiologyYear: 20071001665167010.1016/j.amjcard.2007.06.07118036366
31.. Marcus GM,Rose E,Viloria EM,Schafer J,Marco T,Saxon LA,et al. Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapyJournal of the American College of CardiologyYear: 2005462208221410.1016/j.jacc.2005.05.09516360048
32.. Pitzalis MV,Iacoviello M,Romito R,Guida P,Tommasi E,Luzzi G,et al. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapyJournal of the American College of CardiologyYear: 200545656910.1016/j.jacc.2004.09.05815629375
33.. Seo Y,Ito H,Nakatani S,Takami M,Naito S,Shiga T,et al. The role of echocardiography in predicting responders to cardiac resynchronization therapyCirculation JournalYear: 2011751156116310.1253/circj.CJ-10-086121383516
34.. Russel IK,Zwanenburg JJ,Germans T,Marcus JT,Allaart CP,Cock CC,et al. Mechanical dyssynchrony or myocardial shortening as mri predictor of response to biventricular pacing?Journal of Magnetic Resonance ImagingYear: 2007261452146010.1002/jmri.2113317968903
35.. Torrent-Guasp F,Kocica MJ,Corno AF,Komeda M,Carreras-Costa F,Flotats A,et al. Towards new understanding of the heart structure and functionEuropean Journal of Cardio-Thoracic SurgeryYear: 20052719120110.1016/j.ejcts.2004.11.02615691670
36.. Voigt JU,Schneider TM,Korder S,Szulik M,Gurel E,Daniel WG,et al. Apical transverse motion as surrogate parameter to determine regional left ventricular function inhomogeneities: a new, integrative approach to left ventricular asynchrony assessmentEuropean Heart JournalYear: 20093095996810.1093/eurheartj/ehp06219297386
37.. Lim P,Buakhamsri A,Popovic ZB,Greenberg NL,Patel D,Thomas JD,et al. Longitudinal strain delay index by speckle tracking imaging: a new marker of response to cardiac resynchronization therapyCirculationYear: 20081181130113710.1161/CIRCULATIONAHA.107.75019018725491
38.. Klimusina J,Boeck BW,Leenders GE,Faletra FF,Prinzen F,Averaimo M,et al. Redistribution of left ventricular strain by cardiac resynchronization therapy in heart failure patientsEuropean Journal of Heart FailureYear: 20111318619410.1093/eurjhf/hfq19721106543
39.. Tanaka H,Nesser HJ,Buck T,Oyenuga O,Janosi RA,Winter S,et al. Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the speckle tracking and resynchronization (star) studyEuropean Heart JournalYear: 2010311690170010.1093/eurheartj/ehq21320530502
40.. Boeck BW,Teske AJ,Meine M,Leenders GE,Cramer MJ,Prinzen FW,et al. Septal rebound stretch reflects the functional substrate to cardiac resynchronization therapy and predicts volumetric and neurohormonal responseEuropean Journal of Heart FailureYear: 20091186387110.1093/eurjhf/hfp10719696058
41.. Helm RH,Leclercq C,Faris OP,Ozturk C,McVeigh E,Lardo AC,et al. Cardiac dyssynchrony analysis using circumferential versus longitudinal strain: implications for assessing cardiac resynchronizationCirculationYear: 20051112760276710.1161/CIRCULATIONAHA.104.50845715911694
42.. Bilchick KC,Dimaano V,Wu KC,Helm RH,Weiss RG,Lima JA,et al. Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapyJACC. Cardiovascular ImagingYear: 2008156156810.1016/j.jcmg.2008.04.01319356481
43.. Mangiavacchi M,Gasparini M,Faletra F,Klersy C,Morenghi E,Galimberti P,et al. Clinical predictors of marked improvement in left ventricular performance after cardiac resynchronization therapy in patients with chronic heart failureAmerican Heart JournalYear: 2006151477 e471477 e47610.1016/j.ahj.2005.08.00816442917
44.. St John Sutton MG,Plappert T,Abraham WT,Smith AL,DeLurgio DB,Leon AR,et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failureCirculationYear: 20031071985199010.1161/01.CIR.0000065226.24159.E912668512
45.. Rademakers LM,Kerckhoven R,Deursen CJ,Strik M,Hunnik A,Kuiper M,et al. Myocardial infarction does not preclude electrical and hemodynamic benefits of cardiac resynchronization therapy in dyssynchronous canine hearts circulationArrhythmia and ElectrophysiologyYear: 2010336136810.1161/CIRCEP.109.93186520495014
46.. Chalil S,Foley PW,Muyhaldeen SA,Patel KC,Yousef ZR,Smith RE,et al. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathyEuropaceYear: 200791031103710.1093/europace/eum13317933857
47.. Leyva F,Foley PW,Chalil S,Ratib K,Smith RE,Prinzen F,et al. Cardiac resynchronisation therapy guided by late gadolinium-enhancement cardiovascular magnetic resonanceJournal of Cardiovascular Magnetic ResonanceYear: 2011132910.1186/1532-429X-13-2921668964
48.. Delgado V,Bommel RJ,Bertini M,Borleffs CJ,Marsan NA,Arnold CT,et al. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapyCirculationYear: 2011123707810.1161/CIRCULATIONAHA.110.94534521173353
49.. Faletra FF,Conca C,Klersy C,Klimusina J,Regoli F,Mantovani A,et al. Comparison of eight echocardiographic methods for determining the prevalence of mechanical dyssynchrony and site of latest mechanical contraction in patients scheduled for cardiac resynchronization therapyThe American Journal of CardiologyYear: 20091031746175210.1016/j.amjcard.2009.02.04319539087
50.. Strik, M., Rademakers, L. M., van Deursen, C. J., van Hunnik, A., Kuiper, M., Klersy, C., et al. (2011). Endocardial left ventricular pacing improves cardiac resynchronization therapy in chronic asynchronous infarction and heart failure models. Circulation. Arrhythmia and Electrophysiology. doi:10.1161/CIRCEP.111.965814.
51.. Deursen C,Geldorp IE,Rademakers LM,Hunnik A,Kuiper M,Klersy C,et al. Left ventricular endocardial pacing improves resynchronization therapy in canine left bundle-branch heartsCirculation. Arrhythmia and ElectrophysiologyYear: 2009258058710.1161/CIRCEP.108.84602219843927
52.. Spragg DD,Dong J,Fetics BJ,Helm R,Marine JE,Cheng A,et al. Optimal left ventricular endocardial pacing sites for cardiac resynchronization therapy in patients with ischemic cardiomyopathyJournal of the American College of CardiologyYear: 20105677478110.1016/j.jacc.2010.06.01420797490
53.. Jais P,Takahashi A,Garrigue S,Yamane T,Hocini M,Shah DC,et al. Mid-term follow-up of endocardial biventricular pacingPacing and Clinical ElectrophysiologyYear: 2000231744174711139915
54.. Gelder BM,Scheffer MG,Meijer A,Bracke FA. Transseptal endocardial left ventricular pacing: an alternative technique for coronary sinus lead placement in cardiac resynchronization therapyHeart RhythmYear: 2007445446010.1016/j.hrthm.2006.11.02317399634
55.. Kassai I,Foldesi C,Szekely A,Szili-Torok T. Alternative method for cardiac resynchronization: transapical lead implantationThe Annals of Thoracic SurgeryYear: 20098765065210.1016/j.athoracsur.2008.04.08019161812
56.. Echt DS,Cowan MW,Riley RE,Brisken AF. Feasibility and safety of a novel technology for pacing without leadsHeart RhythmYear: 200631202120610.1016/j.hrthm.2006.06.01217018352
57.. Soliman OI,Geleijnse ML,Theuns DA,Dalen BM,Vletter WB,Jordaens LJ,et al. Usefulness of left ventricular systolic dyssynchrony by real-time three-dimensional echocardiography to predict long-term response to cardiac resynchronization therapyThe American Journal of CardiologyYear: 20091031586159110.1016/j.amjcard.2009.01.37219463520
58.. Bax JJ,Bleeker GB,Marwick TH,Molhoek SG,Boersma E,Steendijk P,et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapyJournal of the American College of CardiologyYear: 2004441834184010.1016/j.jacc.2004.08.01615519016
59.. Yu CM,Lin H,Zhang Q,Sanderson JE. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS durationHeartYear: 200389546010.1136/heart.89.1.5412482792
60.. Suffoletto MS,Dohi K,Cannesson M,Saba S,Gorcsan J 3rd. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapyCirculationYear: 200611396096810.1161/CIRCULATIONAHA.105.57145516476850
61.. Jansen AH,Dantzig J,Bracke F,Meijer A,Peels KH,Brink RB,et al. Qualitative observation of left ventricular multiphasic septal motion and septal-to-lateral apical shuffle predicts left ventricular reverse remodeling after cardiac resynchronization therapyThe American Journal of CardiologyYear: 20079996696910.1016/j.amjcard.2006.11.04417398193
62.. Buss SJ,Humpert PM,Bekeredjian R,Hardt SE,Zugck C,Schellberg D,et al. Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapyJACC. Cardiovascular ImagingYear: 2009253554310.1016/j.jcmg.2009.03.00319442937
63.. Mills RW,Cornelussen RN,Mulligan LJ,Strik M,Rademakers LM,Skadsberg ND,et al. Left ventricular septal and left ventricular apical pacing chronically maintain cardiac contractile coordination, pump function and efficiencyCirculation. Arrhythmia and ElectrophysiologyYear: 2009257157910.1161/CIRCEP.109.88291019843926
64.. Strauss DG,Selvester RH,Wagner GS. Defining left bundle branch block in the era of cardiac resynchronization therapyThe American Journal of CardiologyYear: 201110792793410.1016/j.amjcard.2010.11.01021376930
65.. Rademakers LM. Electrical and hemodynamic benefits of endocardial crt with chronic infarction and LBBBHeart RhythmYear: 20096S237


[Figure ID: Fig1]
Fig. 1 

Typical examples of 3D electrical activation in canine hearts during normal conduction (left panel) and after creation of left bundle branch block (right panel). Each electrical activation map is reconstructed using a single-beat recording of simultaneous epicardial and endocardial electrical mapping. Epicardial potentials were derived using electrode bands placed around the heart, containing over 100 contact electrodes while the LV endocardium was mapped using custom-made plunge electrodes [63]. Early activated regions are indicated by a red color (close to 0 ms) and late activation regions are indicated by a dark blue color (over 100 ms), see color bar. Reproduced with permission [8]

[Figure ID: Fig2]
Fig. 2 

Timing of electrical activation (depolarization) wavefronts in normal conduction and during LBBB shown in sagittal view. For reference, two QRS-T waveforms are shown in their anatomic locations (V3 on the chest and aVF inferiorly). Electrical activation starts at the small arrows and spreads in a wavefront with each colored line representing successive 10 ms. In normal conduction, activation begins within both the LV and RV endocardium. In LBBB, activation only begins in the RV and must proceed through the septum before reaching the LV endocardium. Reproduced with permission [64]

[Figure ID: Fig3]
Fig. 3 

Epicardial isochrone maps during native rhythm in a patient with LBBB. Left anterior escending (LAD) coronary artery is shown and the approximate valve region is covered by gray. Earliest and latest ventricular activation times (in milliseconds) are indicated by framed numbers. Activation times are given with respect to QRS onset. QRSd QRS duration. Reproduced with permission [10]

[Figure ID: Fig4]
Fig. 4 

3D reconstruction of electrical activation times of the LV and the RV during intrinsic conduction (LBBB) and BiV pacing (at the RV apex and basal-lateral LV wall) in representative hearts with LBBB (left), LBBB with LAD infarction (middle), and LBBB with LCX infarction (right). Reproduced with permission [65]

[Figure ID: Fig5]
Fig. 5 

Typical examples of 3D electrical activation in canine hearts with chronic LBBB and transmural myocardial infarction during CRT with epicardial LV pacing (left panel) and endocardial LV pacing (right panel). Reproduced with permission [1]

[TableWrap ID: Tab1] Table 1 

Most accurate (sensitivity > 80%, specificity > 75%, or ROC > 0.80) measurements to detect mechanical discoordination caused by ventricular conduction delay, such as LBBB, in CRT candidates

Author Parameter Design Patients (n) Ischemic etiology (%) Follow-up (months) Cut-off
Echocardiographic measurements of regional delay
Soliman (2009) [57] 3D-SDI SC, obs 90 51 1 >10%
Bax (2004) [58] Ts-4 SC, obs 80 55 6 65 ms
Yu (2003) [59] Ts-SDI2 SC, obs 30 40 3 32.6 ms
Suffoletto (2006) [60] 2D-RS SC, obs 50 62 8 130 ms
Echocardiographic measurements of mechanical discoordination and inefficiency
Jansen (2007) [61] Shuffle and septal motion SC, obs 53 49 3 NA
Buss (2009) [62] EPI SC, obs 42 43 6–8 59%
De Boeck (2009) [40] SRSsept SC, obs 62 44 6.5 4.7%
Lim (2008) [37] Strain-delay SC, obs 62 35 3 25%
Cardiac magnetic resonance measures of dyssynchrony
Bilchick (2008) [42] CURE index SC, obs, control 20 40 / < 0.75

2d-RS speckle tracking radial strain; 3D-SDI standard deviation of 16 time-volume peaks; CURE index circumferential uniformity ratio estimate; EPI echocardiographic phase imaging; obs observational; SC single center; SRS Sept systolic rebound stretch in the septum; Ts-4 maximal velocity delay between four basal segments; Ts-SD12 standard deviation of velocity peaks in 12 basal and midventricular segments

Article Categories:
  • Article

Keywords: Keywords Left bundle branch block, Cardiac resynchronization therapy, Electrical mapping.

Previous Document:  Transcriptome, Proteome, and Metabolome in Dyssynchronous Heart Failure and CRT.
Next Document:  Combining time-resolved fluorescence with synchronous fluorescence spectroscopy to study bovine seru...